Prediction of Risk for Myeloid Malignancy in Clonal HematopoiesisLachelle D. Weeks, Benjamin L. Ebert, Abhishek Niroula et al.|NEJM Evidence|2023Cited by 294
Clonal haematopoiesis and risk of chronic liver diseaseWaihay J. Wong, Stella Aslibekyan, Connor A. Emdin et al.|Nature|2023Cited by 200
Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infectionSeyedeh M. Zekavat, Shigeo Murayama, Derek W. Brown et al.|Nature Medicine|2021Cited by 190
<i>TET2</i>-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Benjamin L. Ebert, Abhishek Niroula et al.|Blood|2022Cited by 150
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic diseaseSeyedeh M. Zekavat, Derek Klarin, Vanesa Viana‐Huete et al.|Nature Cardiovascular Research|2023Cited by 135